Treatment of Toxocara canis infections in mice with liposome-incorporated benzimidazole carbamates and immunomodulator glucan

Journal of Helminthology

Volumn 75, Issue 2, 2001, Pages 141-146

  Hrckova G ^a   Velebny S ^a  

^a PARASITOLOGICAL INSTITUTE   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; ANTIPARASITIC AGENT; BENZIMIDAZOLE DERIVATIVE; DRUG CARRIER; FENBENDAZOLE; GLUCAN; LIPOSOMAL ALBENDAZOLE; LIPOSOMAL FENBENDAZOLE; LIPOSOME; MEBENDAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENTIATION; DRUG RELEASE; EXPERIMENTAL INFECTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; TOXOCARA CANIS; TOXOCARIASIS;

ADJUVANTS, IMMUNOLOGIC; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; FENBENDAZOLE; GLUCANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; LIPOSOMES; MALE; MICE; TOXOCARA CANIS; TOXOCARIASIS; TREATMENT OUTCOME;

EID: 0034798501     PISSN: 0022149X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (45)

1. Anthelmintic effect of levamisole, ivermectin, albendazole and fenbendazole on larval Toxocara canis infection in mice
2. Sterically stabilized ('stealth') liposomes: Pharmacokinetic and therapeutic advantages
3. Albendazole sulfonation by rat liver cytochrome P-450
4. Membrane models with phospholipids
5. Analysis of benzimidazoles in body fluids by high-performance liquid chromatography
6. Pharmacodynamic and toxicological aspects of albendazole in man and animals
7. Influence of the anthelmintic mebendazole on microtubules and intracellular organelle movement in nematode intestinal cells
8. Effect of free and liposomized albendazole on the immune responses in healthy and Toxocara canis infected mice
9. Modification of postoperative C. albicans sepsis by glucan immunostimulation
10. Effect of albendazole in experimental toxocariasis of mice
11. Changes in cellular immunity of mice treated for larval toxocarosis with fenbendazole
12. Reversible depression of the reticuloendothelial system by liposomes
13. Immunomodulatory effect of glucans on professional phagocytes (in Slovak)
14. Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective
15. Toxocara canis infection in the paratenic host: A study on the chemosusceptibility of the somatic larvae in mice
16. The effects of lentinan on production of interleukin-1 by human monocytes
17. Experimental ocular toxocariasis: A mouse model
18. Zoonotic roundworm infections
19. Administration of beta-glucan following Leishmania major infection suppress disease progression in mice
20. The metabolism of benzimidazole anthelmintics
21. Fate of injected liposomes: Observations on entrapped solute retention, vesicle clearance and tissue distribution in vivo
22. Lymphatic transport of liposome-encapsulated agents: Effects of liposome size following intraperitoneal administration
23. Effects of particle size and charge on the clearance of liposomes and liposome-encapsulated drugs
24. Proliposomes of indomethacin for oral administration
25. Human toxocariasis and the visceral larva migrans syndrome: Correlative immunopathology
26. Mode of action of benzimidazoles
27. Comparative efficacy of diethylcarbamazine and mebendazole for the treatment of human toxocariasis
28. Liposome-cell interactions in vitro: Effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes
29. Influence of liposome characteristics on their properties and fate
30. The action of benzimidazoles on the larval stage of Toxocara canis in the mouse
31. Optimal liposomal drug action: From serendipity to targeting
32. Glucan-induced enhancement of host resistance to selected infectious diseases
33. Intrahepatic uptake and processing of intravenously injected small unilamellar phospholipid vesicles in rats
34. Glucan stimulates of antitumour cytolytic, cytostatic factor(s) by macrophages
35. The effect of temperature and antimetabolites on antibody binding to the outer surface of second stage Toxocara canis larvae
36. Effect of glucan immunomodulator on the immune response and larval burdens in mice with experimental toxocarosis
37. Zur wirkung verschiedener benzimidazolcarbamaten auf somatische larven von ancylostoma caninum ercolani 1859 (Ancylostomatidae) und toxocara canis werner 1782 (Anisakidae)
38. Toxocara canis in mice: Are liposomes and immunomodulator able to enhance the larvicidal effect of the anthelmintic?
39. Treatment of larval toxocarosis in mice with fenbendazole entrapped in neutral and negatively charged liposomes
40. Toxocara canis in mice: Effect of stabilised liposomes on the larvicidal efficacy of fenbendazole and albendazole
41. Pharmacology and efficacy of liposome-entrapped albendazole in experimental secondary alveolar echinococcosis and effect of co-administration with cimetidine
42. Monocytotoxic antitumour polysaccharides
43. Glucan-induced modification of murine viral hepatitis
44. Sterically stabilized liposomes
45. Liposomes for oral administration of drug